Dr. Tankovich holds a Master of Science degree in Plasma Physics from Moscow University, an M.D. from Semashco Medical University (Moscow), and a Ph.D. in BioPhysics from Lomonosov Moscow University. He is a recognized innovator, researcher and educator for laser applications in medicine, cancer vaccines, stem cell therapies and other medical related disciplines. As founder and director of several corporations, Dr. Tankovich has more than 100 US and other foreign patents issued and pending, and has published over 60 articles on well-known academic journals.
Dr. Kharazi finished Medical School in 1978 in Kiev, Ukraine, where he earned his medical degree in internal medicine and pathology. From 1978 to 1981, he was a post-doctoral fellow at the Kiev Institute of Gerontology. Dr. Kharazi was one of the first to discover the inhibitory effects of old thymus in mice and later published over 30 papers on this subject. He is a faculty member at the University of Southern California in Los Angeles, and a named inventor of 8 US patents and various foreign patents.
Dr. Verkh has directed national and multi-national Phase I, II, III and IV clinical trials in such areas as cardiology, oncology, neurology, peripheral vascular diseases, hematology, blood disorders and imaging methods. Through his efforts and the efforts of his teams, he has received FDA approval for several products that are currently on the market. Under his leadership, Stemedica obtained several INDs for clinical trials in the United States and emergency INDs from the FDA.